You Aren’t Alone: Navigating The Financial Impact of Cancer
Apr 10, 2024
Monica Fawzy Bryant, Esq.
Dealing with cancer extends beyond physical health, often bringing financial challenges that can overwhelm patients and their loved ones.
In this episode, we offer a beacon of support as we speak to Monica Bryant, Esq., a cancer rights attorney and Co-founder/Chief Operating Officer of Triage Cancer. She reviews the financial hurdles that may arise during treatment and provides practical strategies to help with economic hardships. She also highlights a wealth of resources designed to aid patients, covering everything from financial grants to transportation, Social Security benefits and navigating the complex world of health insurance.
Soy cuidador de un paciente con cáncer. ¿Y ahora qué?
Mar 27, 2024
Mayra Gomez Padua, PhD
Ser cuidador, para muchos es una muestra de compasión. Sin embargo, a medida que pasa el tiempo, muchos cuidadores se encuentran abrumados por el estrés, la carga, y la tristesa asociado con ser un cuidador de alguien dianosticado con cáncer. En muchas ocaciones los cuidadores se encuentran dejando su salud al lado.
En este episodio, la Dra. Mayra Gómez Padua, psicóloga clínica bilingüe nos explica la importancia de mantener el equilibrio entre ser cuidador y manteniendo su autocuidado. Aquí, ella ofrece herramientas y alternativas que ayudarán a los cuidadores navegar de manera efectiva su papel sin tener que sacrificar su bienestar.
Hope for a Rare Disease: Myelofibrosis
Mar 27, 2024
Naveen Pemmaraju, MD
“If you have a rare disease, it’s not rare to you.”
In this episode, Dr. Naveen Pemmaraju of MD Anderson Cancer Center in Houston, TX, sheds light on the latest treatment advancements for myelofibrosis. The pace of scientific discovery for rare diseases is moving at a fast rate, resulting in better outcomes for myelofibrosis patients.
*This episode was recorded on Rare Disease Day, February 29, 2024
How New Therapies Are Changing The Future of Myeloma
Mar 11, 2024
Nishi Shah, MD, MBBS
Remarkable progress has been made in the treatment of myeloma over the past decade, giving patients and families much hope for the future. In this episode, we speak to Dr. Nishi Shah of Montefiore Einstein Comprehensive Cancer Center in New York City. While the wide variety of therapies available to patients are discussed, this episode also focuses on the newest, cutting-edge therapies for myeloma, such as CAR T-cell therapy and bispecific antibodies.
Living with Myeloproliferative Neoplasms (MPNs)
Feb 29, 2024
In the episode, we explore the family of diseases called myeloproliferative neoplasms (MPNs). Dr. Anand Patel and Dr. Olatoyosi Odenike of The University of Chicago Medicine share the latest advances in treatments for MPNs, including myelofibrosis (MF), polycythemia vera (PV) and essential thrombocythemia (ET). We also highlight how treatment teams prioritize the improvement of patients’ quality of life as a key aspect of care.
Bite By Bite: Supporting Cancer Patients Through Nutrition
Feb 09, 2024
Nutrition is a crucial part of cancer care. Many patients and caregivers play an active role in managing their nutrition during and after treatment. In this episode, we discuss nutrition after a cancer diagnosis with Luz Chavez and Susanne Massarani, Registered Dietitians from The University of Chicago. Learn the basics of oncology nutrition and how a good diet can help combat treatment-related weight loss and side effects. Caregivers will also benefit from tips on how to care for their loved ones when they experience appetite changes or other gastrointestinal symptoms.
A diagnosis of cancer can cause significant emotional distress to a patient. A diagnosis of a rare leukemia can leave patients and caregivers feeling unsure and nervous about the future. In this episode, we speak to Dr. Caner Saygin of University of Chicago Medicine about hairy cell leukemia, a rare, but treatable cancer. Dr. Saygin delves into this disease, highlighting the need for an accurate diagnosis, as well as current and emerging treatments. Patients will be given hope for a good quality of life while managing this disease.
Improving Quality of Care for Myelodysplastic Syndromes (MDS)
Jan 10, 2024
Colin Vale, MD
Myelodysplastic Syndromes (MDS) is a group of diseases that have a variety of different treatments and outcomes. In this episode, we speak to Dr. Colin Vale of Emory University in Atlanta, GA, about the treatments for MDS, the potential for transforming into acute myeloid leukemia (AML), and new strategies to give patients the quality of care that they deserve.
Mission To Complete Remission: Utilizing MRD Testing In Blood Cancer
Dec 19, 2023
Adriana Rossi, MD
Testing for minimal or measurable residual disease (MRD) in blood cancer has transformed the way we look at remission and treatment planning.
In this episode, we speak to Dr. Adriana Rossi of Mt. Sinai Hospital in New York about how MRD testing is being utilized for blood cancer patients. Join us as we explore minimal/measurable residual disease (MRD) testing for blood cancer and its role in guiding treatment decisions and predicting relapse and prognosis.
Living A Full Life: Exploring Myeloproliferative Neoplasms (MPNs)
Jun 15, 2023
Myeloproliferative Neoplasms (MPNS) is an umbrella term that includes myelofibrosis (MF), essential thrombocythemia (ET) and polycythemia vera (PV). In this…